Lupin Liquidating Japan JV With Yoshindo, Partners With I’Rom For Denosumab Biosimilar

Also Receives UK Approval For Lutio Generic Version Of Spiriva

 
• By Vibha Ravi
Broken handshake
Lupin is liquidating its share in a Japanese biosimilars JV with Yoshindo • Source: Shutterstock: kuzmaphoto

More from Strategy

More from Business